Product Information
BACLOFEN 25 MG/5 ML SUSPENSION is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $3.7644 per ML under NDC 62559020412. Its NADAC has been published 123 times since May 29, 2024.
FDA first approved this application on Jun 8, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Baclofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559020412
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BACLOFENApproval Type
Generic (ANDA)
FDA Application
ANDA217252FDA Approved
6/8/2023
TE Code
AB
On Market Since
3/18/2024
Pharmacological Classes
Price Statistics
The NADAC for BACLOFEN 25 MG/5 ML SUSPENSION has been published 123 times since May 29, 2024, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7644 per ML |
|---|---|
| All-time high | $4.5131 (Jul 10, 2024) |
| All-time low | $3.7219 (Jul 22, 2026) |
| 52-week high | $4.1143 |
| 52-week low | $3.7219 |
| Median price | $4.0347 |
| Average price | $4.0413 |
| Largest weekly change | -4.8% (Oct 22, 2025) |
| Weeks tracked | 123 |
| Tracking since | May 29, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Baclofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid-ergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BACLOFEN 25 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for BACLOFEN 25 MG/5 ML SUSPENSION, manufactured by ANI Pharmaceuticals, Inc., is $3.7644 per ML (NDC 62559020412), effective Sep 30, 2026.
How has the price of BACLOFEN 25 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for BACLOFEN 25 MG/5 ML SUSPENSION has declined 16.6%. It has been tracked across 123 weekly CMS publications since May 29, 2024.
What are the highest and lowest recorded NADAC prices for BACLOFEN 25 MG/5 ML SUSPENSION?
Since May 29, 2024, the NADAC for BACLOFEN 25 MG/5 ML SUSPENSION has ranged from a low of $3.7219 (Jul 22, 2026) to a high of $4.5131 (Jul 10, 2024), with a median of $4.0347 per ML.
Are there cheaper alternatives to BACLOFEN 25 MG/5 ML SUSPENSION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BACLOFEN 25 MG/5 ML SUSPENSION in a comparable dosage form, but none are currently priced below it.
Who manufactures BACLOFEN 25 MG/5 ML SUSPENSION?
BACLOFEN 25 MG/5 ML SUSPENSION (NDC 62559020412) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.